Drug regulation - Health Canada to publish reasons for drug approvals

被引：0

|

作者：

Eggertson, L

机构：

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2005年 / 172卷 / 11期

关键词：

D O I：

10.1503/cmaj.050506

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1431 / 1431

页数：1

相关论文

共 50 条

[1] THE TIMELINESS OF NEW DRUG APPROVALS IN CANADA
RAWSON, NSB
[J]. INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1995, 25 (01): : 153 - 165
[2] THE TIMELINESS OF NEW DRUG APPROVALS IN CANADA - A REJOINDER
LEXCHIN, J
[J]. INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1995, 25 (01): : 167 - 171
[3] Health Canada shifts focus on drug regulation
[J]. Reactions Weekly, 2007, 1163 (1) : 1 - 1
[4] The characteristics and fulfillment of conditional prescription drug approvals in Canada
Law, Michael R.
[J]. HEALTH POLICY, 2014, 116 (2-3) : 154 - 161
[5] DRUG APPROVALS
MILLER, HI
[J]. NATURE, 1992, 356 (6366) : 189 - 189
[6] Drug approvals
Anon
[J]. Chemical and Engineering News, 2002, 80 (41):
[7] Variation in oncology drug approvals in Canada, the United States and Europe
Khan, O. F.
Samuel, N. N.
Verma, S.
[J]. ANNALS OF ONCOLOGY, 2018, 29
[8] CANADA - EVOLUTION OF DRUG REGULATION WITHIN THE HEALTH PROTECTION BRANCH
WASSENAAR, W
[J]. FOOD AND DRUG LAW JOURNAL, 1980, 35 (08): : 451 - 461
[9] Drug regulation - Health Canada lukewarm on Vioxx panel findings
Murray, S
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (04) : 350 - 350
[10] Speeding Drug Approvals
Mitka, Mike
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (18): : 1904 - 1904

← 1 2 3 4 5 →